ASCENT PHARMACEUTICALS INC

ASCENT PHARMACEUTICALS INC, based in Singapore, is a pharmaceutical manufacturer.

Company Introduction

ASCENT PHARMACEUTICALS INC is a prominent pharmaceutical company operating out of Singapore. It functions primarily as a manufacturer, specializing in the development, production, and marketing of a diverse portfolio of high-quality and affordable generic and over-the-counter (OTC) pharmaceutical products.

The company is committed to advancing global healthcare by providing accessible and reliable medication. Its operations encompass robust research and development capabilities, state-of-the-art manufacturing facilities adhering to stringent international quality standards (such as GMP), and efficient distribution networks. Ascent Pharmaceuticals aims to meet the growing demand for cost-effective therapeutic solutions across various therapeutic areas, serving both domestic and international markets. Their focus is on ensuring product efficacy, safety, and compliance with regulatory requirements.

Ascent Pharmaceuticals Inc. is primarily known as a United States-based generic pharmaceutical company, often operating as a subsidiary of Alvogen. While their products are developed and manufactured for global markets, they are distributed and sold internationally, which may include Singapore.

The company focuses on producing generic versions of various medications across a broad spectrum of therapeutic areas. Their product portfolio typically includes:

Generic oral solid dosage forms such as tablets and capsules

Generic injectable medications

Generic topical creams, ointments, and gels

Generic ophthalmic solutions

Generic liquid solutions and suspensions

These products cover common therapeutic categories including, but not limited to:

Cardiovascular system agents

Central nervous system medications

Gastrointestinal medications

Anti-infective drugs

Pain management medications

Oncology products

Dermatological preparations

Specific product availability in Singapore would depend on local regulatory approvals and distribution agreements. The company's core production and sales strategy revolve around providing cost-effective generic alternatives to branded pharmaceuticals.